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Abstract
Background: Microglia are resident myeloid cells of the central nervous system (CNS) that are maintained by
self-renewal and actively participate in tissue homeostasis and immune defense. Under the influence of endogenous or
pathological signals, microglia undertake biochemical transformations that are schematically classified as the
pro-inflammatory M1 phenotype and the alternatively activated M2 state. Dysregulated proliferation of M1-activated
microglia has detrimental effects, while an increased number of microglia with the alternative, pro-resolving phenotype
might be beneficial in brain pathologies; however, the proliferative response of microglia to M2 signals is not yet known.
We thus evaluated the ability of interleukin-4 (IL-4), a typical M2 and proliferative signal for peripheral macrophages, to
induce microglia proliferation and compared it with other proliferative and M2 polarizing stimuli for macrophages, namely
colony-stimulating factor-1 (CSF-1) and the estrogen hormone, 17β-estradiol (E2).
Methods: Recombinant IL-4 was delivered to the brain of adult mice by intracerebroventricular (i.c.v.) injection; whole brain
areas or ex vivo-sorted microglia were analyzed by real-time PCR for assessing the mRNA levels of genes related with cell
proliferation (Ki67, CDK-1, and CcnB2) and M2 polarization (Arg1, Fizz1, Ym-1) or by FACS analyses of in vivo
BrdU incorporation in microglia. Primary cultures of microglia and astrocytes were also tested for proliferative effects.
Results: Our results show that IL-4 only slightly modified the expression of cell cycle-related genes in some brain areas
but not in microglia, where it strongly enhanced M2 gene expression; on the contrary, brain delivery of CSF-1 triggered
proliferation as well as M2 polarization of microglia both in vivo and in vitro. Similar to IL-4, the systemic E2 administration
failed to induce microglia proliferation while it increased M2 gene expression.
Conclusions: Our data show that, in contrast to the wider responsiveness of peripheral macrophages, microglia proliferation
is stimulated by selected M2 polarizing stimuli suggesting a role for the local microenvironment and developmental origin
of tissue macrophages in regulating self-renewal following alternative activating stimuli.
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Background
Microglia are the resident population of innate immune
cells of the central nervous system (CNS), representing up
to 10% of total brain cells, with differences in cell density
depending on the brain area [1]. It has been demonstrated
that microglia derive from yolk sac progenitors that
colonize the neuroepithelium in early stages of embryogen-
esis [2] and are maintained by self-renewal from embryonal
to adult life by constant and rapid cell turnover, without the
contribution of circulating monocytes [3–5].
Under physiological conditions, microglia display a rami-
fied shape and actively sustain neuronal activity. In analogy
to peripheral tissue macrophages, micro-environmental
and pathogenic stimuli activate microglia to acquire differ-
ent immunometabolic properties that are schematically de-
fined as classical, or “M1,” activation phenotype that is
induced by bacterial or immune molecules, such as lipo-
polysaccharide (LPS) or TNFα, and promotes an inflamma-
tory cytotoxic response; an alternative, “M2” phenotype
that is activated in response to stimuli, such as interleukin
(IL)-4 and IL-13, and allows tissue repair and resolution of
inflammation [6]. Although M1- and M2-like activation
phenotypes have been described in chronic brain diseases,
* Correspondence: elisabetta.vegeto@unimi.it
1Center of Excellence on Neurodegenerative Diseases and Department
Pharmacological and Biomolecular Sciences, University of Milan, Via
Balzaretti, 9, 20133 Milan, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Pepe et al. Journal of Neuroinflammation  (2017) 14:236 
DOI 10.1186/s12974-017-1011-6
still debated are their specific mediators and functions
during neurotoxicity.
Recently, it has been hypothesized that dysregulated
proliferation of microglia plays a detrimental role on
neuronal cell viability, as shown in the case of experi-
mental models of neurodegenerative disorders, such as
Alzheimer’s disease [7–9], amyotrophic lateral sclerosis
[10, 11], and Huntington’s disease [12], as well as acute
CNS injuries [13, 14]. M1-activating stimuli were dem-
onstrated to induce microglia proliferation [15, 16],
while the ability of microglia to proliferate in response
to M2 signals has not been addressed yet. On the con-
trary, IL-4 has been recently shown to induce peripheral
macrophage proliferation [17]; moreover, brain IL-4
levels may increase during pathological events, while ad-
ministration of this molecule associates with beneficial
effects on neuronal survival [18–21]; thus, promoting
proliferation of microglia endowed with pro-resolving
properties may have beneficial effects on disease pro-
gression and offer new therapeutic strategies to select-
ively modulate disease outcome. Interestingly, also
endocrine signals such as the sex steroid hormone 17β-
estradiol (E2) were shown to modulate the phenotypic
activation and to induce proliferation of peritoneal mac-
rophages in vivo, exerting anti-inflammatory effects also
in diverse macrophage populations including microglia
[22, 23].
The aim of this study was thus to assess whether the
M2-like polarization effects of IL-4 in microglia are as-
sociated with a proliferative response. To this purpose,
we analyzed cell proliferation in the mouse brain follow-
ing the intracerebroventricular (i.c.v.) injection of IL-4,
an in vivo method that efficiently induces alternative ac-
tivation of microglia [24]. Our data show that, differently
from peripheral macrophages, microglia do not prolifer-
ate in response to IL-4; similarly, E2 polarizing effects in
microglia are not associated with cell proliferation,
which is instead induced by colony-stimulating factor-1
(CSF-1), a typical macrophage growth factor that also
induces M2 polarization effects.
Methods
Animals and treatments
C57BL/6 female mice of 4 months of age were supplied
by Charles River Laboratories (Calco, Italy). Animals
were allowed to food and water access ad libitum and
kept in temperature-controlled facilities on a 12-h light
and dark cycle. Animals were housed in the animal care
facility of the Department of Pharmacological and
Biomolecular Sciences at the University of Milan.
Animal investigation has been conducted in accord-
ance with the ethical standards and according to the
Declaration of Helsinki and according to the Guide for
the Care and Use of Laboratory Animals, as adopted and
promulgated by the US National Institute of Health, and
in accordance with the European Guidelines for Animal
Care and Use of Experimental Animals.
Female mice identified in metaestrous phase were se-
lected for our analyses; the phase of the reproductive
cycle in female mice was assessed by blind analysis of
vaginal smears mounted on glass microscope slides and
stained with May-Grünwald-Giemsa method (MGG
Quick Stain Kit; Bio-Optica, Milan, Italy) according to
the manufacturer’s protocol.
Mice were injected i.p. with 100 μl of 0.9% NaCl con-
taining 5 μg of mouse recombinant IL-4 (Peprotech,
London, UK). 17β-estradiol (E2; Sigma-Aldrich Corp.,
Milan, Italy) was administered by a 100-μL subcutaneous
(s.c.) injection of 5 μg/kg E2 dissolved in corn oil by stir-
ring in the dark and at room temperature o/n.
For in vivo BrdU labeling experiments, mice were
injected i.p. with 30 μl of a 10 mg/ml solution of BrdU
(Sigma-Aldrich) dissolved in 0.9% NaCl. Animals were
sacrificed 2 h after BrdU injection (n = 6).
Two-day-old newborn rats (CD rats, Charles River)
were supplied by Charles River Laboratories for the
preparation of microglia and astrocytes primary cultures.
Intracerebroventricular injection
Intracerebroventricular (i.c.v.) injections were performed
as previously described [24]. Briefly, mice were anesthe-
tized with a s.c. injection of a ketamine/xylazine solution
(78 and 6 mg/kg, respectively) and positioned on a spe-
cific stand for surgical operation. Injections in the third
cerebral ventricle were performed according to specific
stereotaxic coordinates (bregma, − 0.25 mm; lateral,
1 mm; depth, 2.25 mm). IL-4 was injected at the concen-
tration of 5 μg in 3.0 μl of 0.9% NaCl for expression
studies on purified adult microglia or 250 ng in 2.5 μl
0.9% NaCl for all other experiments; CSF-1 (Peprotech)
was injected at the concentration of 1 μg in 3 μl of 0.9%
NaCl. Animals injected with the same volume of vehicle
alone (0.9% NaCl) were used as controls. Injections were
made using a 26S–gauge Hamilton syringe at a rate of
0.1 μl/3 s, and the needle was kept in place for
additional 30 s and then removed slowly. The skin inci-
sion was closed with a suture and animals were allowed to
recover for 24 h before sacrifice by a lethal ketamine/xyla-
zine solution (150 and 12 mg/kg, respectively). Whole
brains were removed and immediately processed for micro-
glia isolation; brain areas (frontal cortex, hippocampus, and
striatum of left hemisphere, ipsilateral to the injection site)
were collected, immediately frozen on dry ice, and stored at
− 80 °C until processed for RNA preparation. Whole brains
were fixed in 4% formalin solution and stored until proc-
essed for immunohistochemistry.
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Isolation of peritoneal macrophages
After 24 h of IL-4 or vehicle i.p. injections, peritoneal cells
were isolated by peritoneal lavage and incubated with
anti-CD11b antibody-loaded MicroBeads (Miltenyi Biotec,
Bologna, Italy), as previously described [22]. Briefly, 5 ml
of pre-chilled 0.9% NaCl were injected into the peritoneal
cavity using a 21G needle; cell suspension was recovered
and centrifuged; following incubation with ammonium-
chloride-potassium (ACK) solution (0.15 M NH4Cl,
1 mM KHCO3, 0.1 mM EDTA; pH 7.3) for 5 min at 4 °C,
cells were either plated and treated as described in the pri-
mary cell culture section or incubated with cd11b beads
for macrophage purification. For cd11b+ cell isolation,
after washing with PBS + 0.5% BSA, cells were resus-
pended in 90 μL PBS + 0.5% BSA and incubated with
10 μL CD11b MicroBeads for 15 min at 4 °C. After wash-
ing, cells were resuspended in 500 uL PBS + 0.5% BSA
and applied to MS Miltenyi columns (Miltenyi Biotec) for
the magnetic separation procedure. After three washing
steps, CD11b-positive cells were eluted from the columns
and counted. CD11b-positive cells obtained from each
animal were divided into three aliquots; two aliquots of
2.5 × 105 cells each were used to detect BrdU and Ki67 by
flow cytometry, the remaining aliquot was stored in TRI-
zol reagent (Invitrogen-Thermo Fisher Scientific, Milan,
Italy) and used for gene expression studies.
Isolation of microglia from adult brains
After i.c.v. treatments, microglia cells were sorted from
adult brains (n = 4), as previously described [24]. Briefly,
whole brains were dissected and washed in Hank’s balanced
salt solution (HBSS; Life Technologies-Thermo Fisher
Scientific); after removing the meninges, enzymatic cell dis-
sociation was performed using Neural Tissue Dissociation
Kit P (Miltenyi Biotec), with some protocol modifications:
after enzymatic digestion with papain, samples were disso-
ciated mechanically, homogenized, and filtered through a
40-μm cell strainer. After extensive washes in HBSS, myelin
was removed by suspending samples in 10 ml of cold
0.9 M sucrose solution and centrifuging the dissociated
brain cells at 850g and 4 °C for 10 min without braking.
Floating myelin and the supernatant were discarded, and
cells were processed for microglia magnetic sorting by incu-
bating with CD11b MicroBeads (diluted 1:10 in PBS + 0.5%
BSA; Miltenyi Biotec) for 15 min at 4 °C; after washing,
cells were suspended in 500 μl of PBS + 0.5% BSA and ap-
plied to a magnetic column to purify CD11b+ cells. Imme-
diately after isolation, cells were stored in TRIzol reagent
(Invitrogen-Thermo Fisher Scientific) for gene expression.
Primary cell cultures
Peritoneal macrophages
For in vitro assay, peritoneal cells were incubated with
ACK solution, as described above, counted, and seeded
at the concentration of 1 × 106 cells/ml in RPMI +
GlutaMax (Gibco™-Thermo Fisher Scientific) supple-
mented with 10% endotoxin-free FBS, 1% penicillin/
streptomycin, and 1% Na pyruvate (RPMI + 10% FBS).
After 45 min and several washes in PBS, medium was
replaced with RPMI + 10% FBS for IL-4 and CSF-1
treatment and in RPMI w/o phenol red supplemented
with 10% dextran-coated charcoal (DCC)-FBS (RPMI +
10% DCC) for E2 treatment. After 3 h, cells were treated
for 16 h with vehicle or 20 ng/ml of recombinant murine
IL-4 or 20 ng/ml of recombinant murine CSF-1. For es-
trogen treatment, cells were treated on the next day for
3 h with vehicle (0.01% ethanol (EtOH)) or E2 10
5 M.
Astrocytes and microglia cell cultures
Primary cultures of glial cells were prepared from 2-day-
old newborn rats as previously described [25]. After men-
inges removal, brains were mechanically dissociated and
digested in a solution of 2.5% trypsin (Sigma-Aldrich) and
1% DNAse (Sigma-Aldrich), filtered through a 100-μm
cell strainer, and seeded at the confluence of 5 × 106 in a
75-cm2 flask in minimum essential Eagle’s medium
(MEM) supplemented with 10% FBS, 0.6% glucose, 1%
penicillin and streptomycin, and 1% L-glutammine (MEM
+ 10% FBS). Glial cells were grown at 37 °C under a hu-
midified 5% CO2 and 95% air atmosphere, and medium
was replaced every 3 days. After 10 days, microglia were
obtained by shaking the confluent monolayer of mixed
glial cells at 260 rpm for 2 h and seeded in 12-well plates
at the confluence of 5 × 105 cells/well. The medium was
changed with MEM + 15% FBS or MEM + 5% FBS
30 min after microglia plating in order to remove contam-
inating cells. In order to purify astrocytes, enriched astro-
glia cultures following microglia separation were
incubated with 5 mM L-leucine methyl ester (Sigma-Al-
drich) to eliminate contaminating microglia cells and
seeded in six-well plates at the confluence of 5 × 105 cells/
well in MEM + 15% FBS or MEM + 5% FBS.
Astrocytes and microglia were treated for 16 h with
20 ng/ml of recombinant rat IL-4, 20 ng/ml of recom-
binant rat CSF-1 or vehicle. For in vitro proliferation
assay, cells were treated with 10 μM BrdU for 2 h before
cell processing for flow cytometry analysis.
Flow cytometry analysis
For Ki67 staining, cells were fixed in 4% paraformalde-
hyde for 15 min, extensively washed with 125 mM gly-
cine in PBS and permeabilized o/n in PBS containing
0.5% Triton X-100 and 1% BSA, at 4 °C. Cells were incu-
bated with rabbit anti-mouse Ki67 antibody conjugated
with eFluor660 (Affymetrix eBioscience, Milan, Italy) di-
luted 1:100 in incubation solution (PBS containing 0.5%
Triton X-100 and 0.05% BSA) at room temperature for
1 h. After extensive washes in PBS, cells were analyzed
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with a flow cytometry system (NovoCyte® 3000 flow
cytometer, ACEA Biosciences, San Diego, CA) and ana-
lyzed with NovoExpress® Software (ACEA Biosciences).
For BrdU staining, ex vivo peritoneal cells or in vitro
primary cells, detached by 0.25% Trypsin-EDTA (Life
Technology) for astrocytes or Accutase (Merck-Milli-
pore, Vimodrone (MI), Italy) for microglia, were fixed
and permeabilized in 70% EtOH for 30 min at 4 °C and
DNA was denaturated with 2 N HCl/0.5% Triton X-100
and incubated 30 min at room temperature. Cells were
washed with 0.1 M sodium tetraborate (pH 8.5) and in-
cubated with rat anti BrdU antibody (AbD Serotec—Bio-
Rad, Segrate, Italy) diluted 1:100 in incubation solution
(PBS containing 0.05% Tween-20 and 1% BSA). After
washes in PBS + 1% BSA, cells were incubated with
Alexa647-conjugated goat anti-rat secondary antibody
(1:200 in incubation solution; Molecular Probes, Monza,
Italy) for 1 h at room temperature. After extensively
washing with PBS, ex vivo peritoneal macrophages were
resuspended in PI solution (H2O containing 10% NP40,
1 mg/ml RNase A and 5 μg/ml PI stock; Sigma-Aldrich),
instead primary cells were resuspended in PBS. Samples
were analyzed using NovoCyte® 3000 flow cytometer and
analyzed with NovoExpress® Software (ACEA Biosci-
ences). Animals with no pulse of BrdU and in vitro sam-
ples without BrdU treatment were used for gating
strategy to evaluate non-specific signals. Doublets were
removed based on FL2 scatter width (FL2-W)/FL2 scat-
ter area (FL2-A).
RNA preparation and expression analyses
Following 24 h of vehicle or IL-4 (250 ng) i.c.v. treat-
ment, brain area (frontal cortex, striatum, and hippo-
campus) were first homogenized using steel beads and
tissue Lyser (Qiagen, Milan, Italy) at 28 Hz, for three cy-
cles of 20 s followed by 30 s, on ice and in RLT buffer.
Total RNA from tissue or cells was purified using
RNeasy minikit protocol (Qiagen), according to the
manufacturer’s instructions, including a step with deoxy-
ribonuclease incubation. For real-time PCR, 1 μg RNA
(500 ng for striatum and primary cultures, 100 ng for
isolated microglia, 300 ng for ex vivo peritoneal macro-
phages) was used for cDNA preparation using 8 U/μl of
Moloney murine leukemia virus reverse transcriptase
(Promega, Milan, Italy) in a final volume of 25 μl; the re-
action was performed at 37 °C for 1 h, and the enzyme
inactivated at 75 °C for 5 min. Control reactions without
the addition of the reverse transcription enzyme were
performed (data not shown). A 1:4 cDNA dilution was
amplified using GoTaq®qPCR Master Mix technology
(Promega) according to the manufacturer’s protocol.
The PCR was carried out in triplicate on a 96-well plate
using QuantStudio® 3 real-time PCR system (Applied
Biosystems-Thermo Fisher Scientific) with the following
thermal profile: 2 min at 95 °C; 40 cycles, 15 s at 95 °C,
1 min at 60 °C. Primer sequences are reported in
Additional file 1: Table S1. Data were analyzed using the
2−ΔΔCt method.
Immunohistochemistry
Brains were trimmed using a brain matrix (Adult Mouse
Brain Slicer Matrix BSMAS005-1, Zivic Instruments, Pitts-
burgh, PA, USA), and sections were routinely processed,
paraffin embedded, and sectioned in 4-μm serial sections.
After heat-induced epitope retrieval, performed in Dewax
and HIER Buffer H (TA-100-DHBH, Thermofisher Scien-
tific, Waltham, MA, USA) for 40 min at 94 °C, sections
were incubated with a 10% normal goat serum for non-
specific binding blocking. Sections were immunostained
with rabbit polyclonal anti-Ki67 antibody (Clone SP6,
Thermo Fisher Scientific, Waltham, MA, USA), incubated
with biotinylated goat anti-rabbit secondary antibodies
(VC-BA-1000-MM15, Vector Laboratories, Peterborough,
UK) and labeled by the avidin-biotin-peroxidase procedure
with a commercial immunoperoxidase kit (VECTASTAIN®
Elite ABC-Peroxidase Kit Standard, VC-PK-6100-KI01,
Vector Laboratories). The immunoreaction was visualized
with DAB (Peroxidase DAB Substrate Kit, VC-SK-4100-
KI01, Vector Laboratories) substrate, and sections were
counterstained with Mayer’s hematoxylin (C0302, Diapath,
Italy). Digital image analysis was performed by scoring the
number of Ki67-positive cells in three ×400 microscopic
fields in the parenchyma of vehicle, IL-4 and CSF-1-treated
mice (n = 3); monocyte-like cells were excluded from the
analysis. For double immune-fluorescence analysis, after
heat-induced antigen retrieval in Dewax and HIER BufferH
pH 9 (Thermofisher Scientific) and anti-ki67 antibody
(RM-9106, Thermofisher Scientific) incubation, goat anti-
rabbit green fluorescent antibody (Alexa Fluor 488, Thermo
Fisher Scientific) was used; after washing with PBS, sections
were re-incubated with anti-GFAP (Z0334, from DAKO
Agilent, Santa Clara, CA, USA) or anti-Iba1 (Wako
Chemicals USA, Richmond, VA) for 1 h at room
temperature followed by a goat anti-rabbit red fluorescent
secondary antibody (Alexa Fluor 555, Thermo Fisher scien-
tific). Sections were mounted on coverslips with ProLong
Gold Antifade mountant with DAPI (P36941, Thermofisher
Scientific).
Statistical analyses
Unless otherwise stated, all values are expressed as
mean ± standard error of the mean (SEM) of n observa-
tions. The results were analyzed by the Student unpaired
two-tailed t test using GraphPad Prism 5 software, after
a normality test (Kolmogorov-Smirnov) [26]. A value of
p < 0.05 was considered significant.
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Results
Peritoneal macrophage proliferation following the local
delivery of IL-4
In order to analyze the proliferative activity of IL-4 in
the brain, we first set up in vivo proliferative assays on
macrophages in the peritoneum, a peripheral tissue
where resident macrophages were shown to increase in
number in response to this immune signal [17]. Periton-
eal macrophages were collected from the peritoneal lav-
age of mice 24 h after an i.p. injection of IL-4 and
further purified by immunosorting; a control group of
mice were injected with vehicle alone. As shown in
Fig. 1a, the levels of mRNA coding for proteins related
with proliferation (Ki67) and cell cycle (CcnB2 and
Cdk1) were increased following IL-4 injection as com-
pared to control mice, suggesting a proliferative effect of
IL-4; as expected, the expression of M2 genes, namely
Arg1, Fizz1, and Ym1, was also strongly induced by IL-4
(see Fig. 1b).
In order to confirm the effect of IL-4 on cell cycle
entry and DNA synthesis, FACS analyses were con-
ducted on peritoneal macrophages to evaluate Ki67 pro-
tein levels and BrdU incorporation, respectively. The
results shown in Fig. 2 demonstrate that IL-4 is a prolif-
erative signal for peritoneal macrophages, leading to an
increase in ki67-positive and in duplicating peritoneal
macrophages of 10 and 6%, respectively. Accordingly,
the number of recovered macrophages from peritoneal
fluid was more elevated in IL-4-treated mice (data not
shown).
Altogether, these results show that locally delivered IL-
4 is a proliferative signal for peritoneal macrophages.
Brain delivery of IL-4 has limited effects on brain cell
proliferation
We then extended our observation to evaluate the pro-
liferative response of microglia following IL-4 injection
in the cerebral ventricles of mice. Cell cycle gene expres-
sion was analyzed by real-time PCR in diverse brain
areas and, unexpectedly, the mRNA levels coding for
Cdk1 and Ki67 were only slightly increased by IL-4, with
a twofold induction compared to control samples in the
cortex and hippocampus and not in the striatum, while
Ccnb2 expression was not modified in any brain areas
analyzed (see Fig. 3a). On the other hand, the i.c.v. injec-
tion of IL-4 induced the expression of M2 polarization
signals, as shown in Fig. 3b: a strong induction of Arg1,
Fizz1, and YM-1 mRNAs was generally observed in all
brain areas with different region-specific intensities, as
already reported [24]. Thus, IL-4-induced polarization is
associated with little proliferative effects in the brain.
To further investigate brain cell proliferation following
IL-4, we analyzed Ki67 protein expression by immunohis-
tochemistry. The results are reported in Fig. 4 and show
that some Ki67-positive cells were present in the cortex
and even more in the hippocampus of vehicle-treated
mice, while no positively stained cells were detected in the
striatum (data not shown); in this experimental condi-
tions, we calculated that Ki67-positive cells are about 1
and 2.7% of total parenchymal cells in the cortex and
hippocampus, respectively (see Fig. 4g); IL-4 administra-
tion resulted in a statistically significant increase in Ki67-
positive cells in the cortex and hippocampus, while no
signal was detected in the striatum (see Fig. 4). The mor-
phological appearance of most of the Ki67-positive cells
did not recall the microglial cell shape, both in vehicle-
and IL-4-treated brains.
It is known that tissue microenvironment substantially
shapes macrophage responsiveness. In order to exclude
the possibility that general brain-specific mechanisms
could silence proliferative signaling pathways in micro-
glia under non-pathological conditions, we evaluated the
activity of CSF-1, the best-known proliferative agent for
macrophages. Fig. 4c, f shows that the i.c.v delivery of
CSF-1 triggers the proliferation of brain cells, some of
which displaying a microglia-like morphology, and re-
sults in a fivefold increase in ki67-positive cells in the
cortex and hippocampus with respect to vehicle and
twofold in the striatum, effects that are also significantly
different from those obtained with IL-4 (see Fig. 4g). In
addition, some Ki67-positive monocyte-like cells were
observed in brain vessels after both IL-4 and CSF-1
treatments (see Fig. 4e, j), suggestive of the recruitment
of proliferating monocytes.
Altogether, these data show that, in the adult mouse
brain, an increase in IL-4 level does not associate with a
proliferative response and suggest that this molecule
might not be a proliferative signal for microglia, differ-
ently from its effects on peritoneal macrophages.
Proliferative activity of M2 polarization signals on
microglia in vivo and in vitro
Since microglia represent only 10% of all brain cells, and
considering the restricted percentage of IL-4 responder
cells in terms of proliferation in the periphery (see Fig. 2),
we evaluated whether the mild proliferative response re-
ported in Fig. 3a could be ascribed to a small subset of
microglia. Microglia were purified from the brain of ve-
hicle or IL-4-injected mice and analyzed for proliferative
parameters. Notably, Ki67 and cell cycle mRNA levels
were not increased in response to i.c.v. IL-4, as shown in
Fig. 5a; on the contrary, increased levels of mRNA cod-
ing for proteins related with M2 polarization (Arg1,
Fizz1, and Ym1) were detected in microglia purified
from IL-4 as compared to vehicle-treated mice. These
results suggest that brain cells other than microglia are
induced to moderately proliferate in response to IL-4.
Pepe et al. Journal of Neuroinflammation  (2017) 14:236 Page 5 of 13
Fig. 1 Expression of cell cycle and M2 polarization genes in peritoneal macrophages following IL-4 treatment in vivo. The expression of genes related
with a cell proliferation (Ki67, Cdk1, and CcnB2) and b M2 alternative polarization (Arg1, Fizz1, and Ym1) was analyzed by real-time PCR in peritoneal
macrophages isolated from mice treated i.p. with vehicle (veh) or 5 μg IL-4 for 24 h. Data sets for each gene were calculated using the 2-ddCt method
with respect to the mean value of the vehicle group. Bars represent mean values ± SEM (n = 2–6). Student’s unpaired t test, *p < 0.05; **p < 0.01;
***p < 0.001 versus veh
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On the contrary, CSF-1 brain delivery resulted in a sig-
nificantly increased expression of genes related with pro-
liferation and cell cycle specifically in microglia, as
shown in Fig. 5a; as expected since CSF-1 is endowed
with M2 polarization effects, we observed a parallel en-
hancement of M2 polarization genes such as Arg1, Fizz
1, and Ym1.
We then asked whether 17-beta-estradiol (E2), a lipo-
philic hormone that reduces microglia inflammatory
phenotype, could alter microglia proliferation in line
with the recent observation on its proliferative effect on
peripheral macrophages [22, 23, 27, 28]. Similar to what
is observed with IL-4, systemic administration of physio-
logical doses of E2 caused a significant increase in the
mRNA coding for Fizz1 and Ym1 in microglia, while cell
cycle genes were unaffected (Fig. 5b).
Thus, these data show that under homeostatic condi-
tions, microglia can proliferate in response to some M2-
activating signals, such as CSF-1, but not IL-4 and E2.
During the perinatal period, microglia proliferation
and development are strongly active processes; we thus
asked whether IL-4 might associate with proliferative ef-
fects on microglia from this developmental stage. As
shown in Fig. 6a, IL-4 treatment of microglia primary
Fig. 2 Proliferation of peritoneal macrophages following IL-4 treatment in vivo. Ki67 protein expression (a, b) and BrdU incorporation (c, d) were analyzed
in peritoneal macrophages isolated from mice treated i.p. with vehicle (veh) or 5 μg IL-4 for 24 h. a, c show representative dot plots depicting gating
schemes for Ki67 and BrdU analyses, respectively. Bar charts represent the percentage of macrophages showing a positive signal for Ki67 (b) or BrdU (d)
with respect to the total number of macrophages obtained from each mouse following the specified treatment. Bars represent the mean ± SEM of six mice
per group. Student’s unpaired t test, ***p < 0.001
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cultures from newborn animals did not modify Ki67 and
Cdk1 expression, while CSF-1 still resulted in increased
Ki67 and Cdk1 mRNA levels. The ability of microglia to
proliferate in response to CSF-1 was further demon-
strated by BrdU incorporation analyses as a biological
evidence of proliferation, while no signs of proliferation
were observed following IL-4 under different experimen-
tal conditions such as reduced serum concentrations
(see Fig. 6b). Gene expression analyses demonstrated
that the alternative phenotype is induced in these cells
by IL-4 and CSF-1, although with different intensities
(see Additional file 2: Figure S1A). Lack of a proliferative
response of microglia could not be ascribed to a reduced
sensibility of microglia, since the expression of the IL-4
receptor (IL-4Rα) in ex vivo-sorted or in vitro microglia
did not vary in response to IL-4 (see Additional file 2:
Figure S1B). We also tried to extend our observation to
other primary macrophages obtained from adult animals;
however, CSF-1 as well as IL-4 and E2 failed to induce
proliferation of peritoneal macrophages while still retain-
ing their polarization effects (see Additional file 3: Figure
S2), in agreement with recent observation using similar
experimental conditions [22, 29].
In parallel, primary cultures of astrocytes were also
assayed for their proliferative response to IL-4; although
cell cycle gene expression was unchanged, BrdU incorp-
oration assay revealed a slight yet significant increase in
the number of astrocytes in the S-phase of the cell cycle
following IL-4, suggesting that the proliferative response
observed in the brain following i.c.v. IL-4 (reported in
Figs. 3 and 4) can be ascribed, at least in part, to astro-
cytes. Indeed, double immune staining of brain sections
following i.c.v IL-4 shows co-localization of Ki67 signal
with about 1% of GFAP-positive cells (see
Additional file 4: Figure S3), and not Iba1-positive cells.
Altogether, these data show that microglia in the brain
of adult mice are activated by M2 signals, such as IL-4,
CSF-1, and E2, to shape their immune phenotype while
self-renewal is specifically triggered by CSF-1; IL-4 and
E2 brain activities do not correlate with microglia cell
expansion, in contrast to what has been observed for
peripheral macrophages, as summarized in Fig. 7.
Discussion
The present study provides the first evidence to show
that microglial cells do not proliferate in response to IL-
4, at least in the present experimental conditions; in fact,
using molecular and biological assays, we were unable to
detect microglia proliferation following IL-4 treatment
both in vivo in the mouse brain and in vitro on primary
Fig. 3 Brain expression of cell cycle and M2 polarization genes following local delivery of IL-4. Mice were injected i.c.v. with vehicle (veh) or 250 ng IL-4;
the cortex, striatum, and hippocampus were isolated and analyzed by real-time PCR for the expression of genes related with a cell cycle (Ki67, CcnB2, and
Cdk1) and b M2 alternative polarization (Arg1, Fizz1, and Ym1). Data sets for each gene were calculated using the 2-ddCt method with respect to the mean
value of the vehicle group. Bars represent mean values ± SEM (n = 5). Student’s unpaired t test, *p < 0.05; **p < 0.01 versus veh
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cultures microglia from newborn animals. On the con-
trary, this immune mediator enhances the proliferation
of peripheral macrophages, as shown in this and previ-
ous studies [17]. Moreover, also another M2-activating
signal, namely E2, showed a similar polarization and
non-proliferative activity in microglia of adult mice.
Microglial population is expanded during the patho-
logical course of neurodegenerative diseases and contrib-
utes to disease progression [7–12]; the activity of IL-4 in
brain recently received considerable attention in relation
with its anti-inflammatory and pro-resolution effects that
are directly mediated by microglia. Expression and secre-
tion of IL-4 is induced by neuroinflammatory insults in
activated immune cells and damaged neurons and IL-4-
activated microglia produce a series of mediators,
including neurotrophic factors, matrix remodeling, and
proteolytic enzymes that help reduce neuroinflammation
and promote tissue repair, as shown in experimental
models of neurodegenerative diseases [18, 21, 30–32]. It is
thus important to understand whether IL-4 contributes to
the expansion of microglia that undergoes an alternative
activation phenotype. In this scenario, our results provide
an important step forward, as we show that IL-4 activity
in the brain, although associated with immunoregulatory
and tissue repair phenotype, does not correlate with an in-
crease in microglia number. Analogously, estrogen action
in microglia has been proposed to mediate the protective
effects observed for this hormone against neurodegenera-
tive diseases in humans and animal models, while the re-
duction in estrogen levels that occurs at menopause is
associated with an increased incidence of neuroinflamma-
tory pathologies [33]. Previous studies reported the effects
on microglia polarization when E2 was assayed together
with neuro-immune signals [23, 34]; the present study is
the first evidence to show that E2 per se promotes micro-
glia alternative polarization.
Fig. 4 Ki67 protein expression in brain areas following local delivery of IL-4 and CSF-1. Following the i.c.v. injection of vehicle (veh; a, d), 250 ng
IL-4 (b, e, and h) and 1 μg CSF-1 (C, F and J) brains were processed by immunohistochemistry to visualize Ki67 expression. Images were taken
from the cortex (a–c) and hippocampus (d–f) of mice. Histograms in g show the quantification of the percentage of Ki67-positive cells with
respect to the total number of cells in brain areas, as specified; h, j monocyte-like cells were detected in brain vessels from IL-4- and CSF-1-treated
mice, respectively and excluded from the counting. Bars represent mean values ± SEM (n = 3). Student’s unpaired t test, *p < 0.05 versus veh; °
p < 0.05 versus IL-4. Scale bar, 100 μm
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Our results highlight a substantial difference between
microglia and peripheral macrophage biology in their re-
sponsiveness to M2-activating signals, as shown in Fig. 7.
These two resident macrophage populations have a dif-
ferent developmental origin and acquire both common
and specialized functions during life; indeed, a marked
difference in the gene expression profiles has been ob-
served in microglia as compared with other macrophage
populations [35]. Moreover, it is known that the sur-
rounding microenvironment is crucial to modulate
macrophage functions by providing tissue-specific sig-
nals and interactions that influence cell phenotype and
responsiveness. However, explanations for the lack of
microglia proliferation are still missing; one could
hypothesize that specific alterations of the IL-4 signaling
pathway that converges on cell proliferation are present
in microglia as compared to peripheral macrophages; a
possible candidate is the phosphatidylinositol-3 kinase
(PI3K)/Akt pathway, which has been shown to be neces-
sary for the IL-4 activity on the proliferative burst of
peripheral macrophages [29, 36]; instead, proliferative
responses of macrophages to E2 are still ill defined. On
the other hand, our data show that the proliferative sig-
naling of CSF-1R is maintained in microglia, in agree-
ment with previous reports [7, 37–39] which also
Fig. 5 In vivo effects of M2 polarization signals on microglia gene
expression. Microglia were isolated by immunosorting 24 h after a i.c.v.
injections of vehicle (veh; open boxes), 5 μg IL-4 (closed boxes) or 1 μg
CSF-1 (gray boxes) or b s.c. 17β-estradiol (E2) treatment (5 μg/kg). The
expression of genes related with active replication and cell cycle (Ki67;
Cdk1, Ccnb2) and M2 alternative polarization (Arg1, Fizz1, Ym1) was
analyzed by real-time PCR. Data sets for each gene were calculated
using the 2-ddCt method with respect to the mean value of the vehicle
group. Bars represent mean values ± SEM (n = 4). Student’s unpaired t
test, *p < 0.05; **p < 0.01; ***p < 0.001 versus veh
Fig. 6 Proliferative responses of primary cultures of microglia and
astrocytes. a The expression of proliferation genes (Ki67 and Cdk1)
was analyzed in primary cultures of microglia and astrocytes
following vehicle (veh; open boxes), 20 ng/ml IL-4 (closed boxes) or
20 ng/ml CSF-1 (gray boxes) treatments. Bars represent the mean ±
SEM of three independent experiments, each performed in triplicate.
Data sets for each gene were calculated using the 2-ddCt method
with respect to the mean value of the vehicle group. Bars represent
mean values ± SEM (n = 3). Student’s unpaired t test, **p < 0.01;
***p < 0.001. b BrdU incorporation was evaluated by flow cytometry
in microglia and astrocytes treated with 20 ng/ml IL-4 (closed boxes)
or 20 ng/ml CSF-1 (gray boxes) added to culture medium containing
high (15%) or low (5%) serum concentrations. Bars represent the
mean ± SEM of three independent experiments, each performed in
triplicate (n = 3). Student’s unpaired t test, *p < 0.05; **p < 0.01;
***p < 0.001 versus vehicle; °°°p < 0.001 versus vehicle high FBS
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associated CSF-1 activity with the PI3K pathway. Thus,
the specific effects of CSF-1 and IL-4 signaling pathways
on microglia proliferation might either involve cell-
specific mediators of the PI3K pathway or yet undefined
PI3K-unrelated processes.
Our study also shows that the in vivo effects of CSF-1 ex-
tend to the induction of an M2-like phenotypic activation of
brain cells, similar to the response of peritoneal macrophages
in vivo, as shown here, or in vitro, as previously reported
[40]; interestingly, an opposite effect on Fizz1 expression in
brain and peritoneal macrophages was observed, as well as
the induction of specific M2 genes in primary cultures of
microglia; these features need future investigation, although
the experimental procedures and development stage used
for culturing primary microglia cells may alter cell respon-
siveness and limit any comparison with resident microglia of
the adult brain. The use of CSF-1R inhibitors in experimen-
tal models of neurodegenerative pathologies has been shown
to reduce microglia density and to associate with beneficial
effects against disease progression, although still unclear are
the consequences of CSF-1R inhibition on polarized pheno-
type effectors, as well as the role of CSF-1R-independent
and/or compensating pathways in microglia self-renewal and
turnover [5, 7, 11, 41, 42]. Environmental and pathological
signals seem to influence the type, timing, and resolution of
microglia polarization responses through ill-defined mecha-
nisms that differ between the healthy and injured brain and
that need deeper investigation.
Conclusions
The uncoupling of the polarization and proliferative
activities of IL-4 and E2 in microglia is unclear; indeed,
several aspects of microglia polarization have not been
yet investigated, such as the fate of these cells following
activation or the existence of local amplifiers of alterna-
tive polarization responses, which have only recently
been identified for IL-4 in some peripheral tissues [43].
Thus, further studies are needed to understand the mo-
lecular mechanisms of microglia proliferation, with the
aim of opening novel therapeutic strategies that select-
ively and timely potentiate alternatively activated micro-
glia while avoiding inflammatory macrophage expansion
and monocyte recruitment.
Additional files
Additional file 1: Table S1. Oligonucleotides used in real time PCR
assays. (PDF 182 kb)
Additional file 2: Figure S1. In vitro polarization responses of microglia
to IL-4 and CSF-1. A) The expression of M2 polarization genes (Arg1 and
Mrc1) was analyzed in primary cultures of microglia following the treatment
with vehicle (veh; open boxes), 20 ng/ml IL-4 (closed boxes) or 20 ng/ml
CSF-1 (gray boxes). B) The expression of IL-4Rα was analyzed either in
microglia cells obtained by immunosorting from the brain of vehicle or IL-4
icv-injected mice (ex vivo) or in primary cultures of microglia (in vitro) as
specified above. Bars represent the mean ± SEM of 3 independent
experiments, each performed in triplicate. Data sets for each gene were
calculated using the 2-ddCt method with respect to the mean value of the
vehicle group. Bars represent mean values ± SEM (n = 3). Student’s unpaired
t-test, *p < 0.05; **p < 0.01; ***p < 0.001. (PDF 167 kb)
Additional file 3: Figure S2. In vitro proliferative and polarization
responses of macrophages to IL-4, CSF-1 and E2. A) The expression of
proliferation (Ki67, Cdk1 and Ccnb2) and M2 polarization (Arg1, Fizz1,
Mrc1) genes was analyzed in primary cultures of peritoneal macrophages
following treatment with 20 ng/ml IL-4 (black bars) or 20 ng/ml CSF-1
(gray bars). B) The expression of proliferation (Ki67, Cdk1 and Ccnb2) and
M2 polarization (Arg1, Vegfα) genes was analyzed in primary cultures of
peritoneal macrophages following vehicle (0.01% EtOH) or 10−5 M E2
treatments. Bars represent the mean ± SEM of 3 independent experiments,
each performed in triplicate Data sets for each gene were calculated using the
2-ddCt method with respect to the mean value of the vehicle group. Bars
Fig. 7 Tissue-specific responses of resident macrophages to polarization signals. Resident macrophages in the peritoneum show proliferative and
alternative polarization responses to IL-4, CSF-1, and E2; in the brain, alternative polarization of microglia is induced by the same signals, although
with different intensities and target gene-specificity, while cell proliferation is restricted to CSF-1 signaling
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represent mean values ± SEM (n = 3). Student’s unpaired t-test, *p< 0.05;
***p < 0.001. (PDF 339 kb)
Additional file 4: Figure S3. Cellular localization of Ki67
immunostaining in brain astrocytes. Brain sections were analyzed by
immunohistochemistry for the expression of Ki67 using antibodies
against Ki67 (green labeling) and GFAP (red staining) following the icv
administration of 250 ng IL-4. Ki67-positive cells co-localize with GFAP-po-
sitive cells (white arrows). Scale bar, 10 μm. (PDF 105 kb)
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